*Feinberg School of Medicine

‡Department of Neurology

§Department of Neurological Surgery

∥Chief, Neuropathology Division, Departments of Pathology and Neurosurgery

**Associate Chief, Neuro-Oncology Division, Department of Neurology

†University of Chicago Medicine, University of Chicago, Chicago

¶Hematology, BMT/Cellular Therapy and Clinical Apheresis Programs, Cancer Treatment Centers of America, Zion

#Rosalind Franklin University of Medicine and Science, IL

R.L.: speakers’ bureau for Merk and Novocure, scientific advisory board for Merck, research support (drug only) from BMS. The remaining authors declare no conflict of interest.

Correspondence to: Rimas V. Lukas, MD, Associate Chief, Neuro-Oncology Division, Associate Professor, Ambulatory Medical Director, Department of Neurology, Lou & Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL. E-mail: [email protected].